Onconetix, Inc. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
This filing contains only Sarbanes-Oxley officer certifications (Exhibits 31.1, 31.2, 32.1, 32.2) signed by CEO David Allan White and Interim CFO Karina M. Fedasz, dated August 13, 2026 for the quarterly period ended June 30, 2026. The certifications attest to the accuracy and reliability of the financial statements and disclosure controls. No operational, financial, or strategic information is disclosed in this excerpt.
Why this rating
Routine boilerplate SOX certifications. No substantive business information disclosed; filing excerpt contains only regulatory compliance exhibits with no financial data, deals, or operational changes to evaluate.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.